These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31668830)

  • 1. Δ
    Doss MK; Weafer J; Gallo DA; de Wit H
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Jan; 5(1):110-118. PubMed ID: 31668830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Δ
    Doss MK; Weafer J; Gallo DA; de Wit H
    Biol Psychiatry; 2018 Nov; 84(10):743-750. PubMed ID: 29884456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoactive drugs and false memory: comparison of dextroamphetamine and δ-9-tetrahydrocannabinol on false recognition.
    Ballard ME; Gallo DA; de Wit H
    Psychopharmacology (Berl); 2012 Jan; 219(1):15-24. PubMed ID: 21647577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
    Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dark Side of Context: Context Reinstatement Can Distort Memory.
    Doss MK; Picart JK; Gallo DA
    Psychol Sci; 2018 Jun; 29(6):914-925. PubMed ID: 29671680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.
    Ramaekers JG; Theunissen EL; de Brouwer M; Toennes SW; Moeller MR; Kauert G
    Psychopharmacology (Berl); 2011 Mar; 214(2):391-401. PubMed ID: 21049267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
    Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
    J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
    Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
    Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
    Lile JA; Kelly TH; Hays LR
    Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and residual mood and cognitive performance of young adults following smoked cannabis.
    Matheson J; Mann RE; Sproule B; Huestis MA; Wickens CM; Stoduto G; George TP; Rehm J; Le Foll B; Brands B
    Pharmacol Biochem Behav; 2020 Jul; 194():172937. PubMed ID: 32360692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis.
    Gupta S; De Aquino JP; D'Souza DC; Ranganathan M
    Psychopharmacology (Berl); 2019 Sep; 236(9):2635-2640. PubMed ID: 30919005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers.
    Schindler EAD; Schnakenberg Martin AM; Sewell RA; Ranganathan M; DeForest A; Pittman BP; Perrino A; D'Souza DC
    Psychopharmacology (Berl); 2020 Oct; 237(10):3097-3107. PubMed ID: 32632491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
    Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
    Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.
    Huestis MA; Elsohly M; Nebro W; Barnes A; Gustafson RA; Smith ML
    Ther Drug Monit; 2006 Aug; 28(4):540-4. PubMed ID: 16885722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
    Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
    Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
    D'Souza DC; Braley G; Blaise R; Vendetti M; Oliver S; Pittman B; Ranganathan M; Bhakta S; Zimolo Z; Cooper T; Perry E
    Psychopharmacology (Berl); 2008 Jul; 198(4):587-603. PubMed ID: 18228005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
    Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
    J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.